MOH — authorised 23 February 2015
- Marketing authorisation holder: NOVARTIS PHARMS CORP
- Status: likely_approved
🇮🇱 Farydak in Israel
MOH authorised Farydak on 23 February 2015
Marketing authorisation
Farydak in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Farydak approved in Israel?
Yes. MOH authorised it on 23 February 2015.
Who is the marketing authorisation holder for Farydak in Israel?
NOVARTIS PHARMS CORP holds the Israeli marketing authorisation.